Ilya M. Rachman - 17 Sep 2025 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)

Role: CEO and Chairman, Director
Signature: /s/ Ilya Rachman
Issuer symbol: IMMX
Transactions as of: 17 Sep 2025
Net transactions value: +$5,050
Form type: 4
Filing time: 17 Sep 2025, 17:20:33 UTC
Previous filing: 23 Jun 2025
Next filing: 10 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Rachman Ilya M	CEO and Chairman, Director	C/O IMMIX BIOPHARMA, INC., 11400 WEST OLYMPIC BLVD., SUITE 200, LOS ANGELES	/s/ Ilya Rachman	17 Sep 2025	0001889334

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMMX	Common Stock	Purchase	$5,050	+2,500	+0.22%	$2.02	1,140,937	17 Sep 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Volume-weighted average price of purchases which transactions occurred at purchase prices from $2.01 to $2.02 per share, inclusive. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.